Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126186443 | 12618644 | 3 | F | 20160817 | 20160818 | 20160803 | 20160824 | EXP | PHHY2016PA106189 | NOVARTIS | 86.53 | YR | F | Y | 0.00000 | 20160824 | MD | PA | PA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126186443 | 12618644 | 1 | PS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | PATCH (10 CM2), QD | U | 22083 | 9.5 | MG | TRANS-THERAPEUTIC-SYSTEM | QD | |||||
| 126186443 | 12618644 | 2 | C | IRBESARTAN. | IRBESARTAN | 1 | Oral | 300 MG, QD | U | 0 | 300 | MG | QD | ||||||
| 126186443 | 12618644 | 3 | C | QUETIAZIC | 2 | Unknown | 100 MG, QHS | U | 0 | 100 | MG | ||||||||
| 126186443 | 12618644 | 4 | C | AKATINOL | 2 | Oral | 10 MG, QD | U | 0 | 10 | MG | QD | |||||||
| 126186443 | 12618644 | 5 | C | EXPANSIA | 2 | Oral | 75 MG, QW2 | U | 0 | 75 | MG | BIW | |||||||
| 126186443 | 12618644 | 6 | C | CORYOL | CARVEDILOL | 1 | Oral | 6.25 MG, (HALF DAY) | U | 0 | 6.25 | MG | TABLET | ||||||
| 126186443 | 12618644 | 7 | C | ALDACTONE | SPIRONOLACTONE | 1 | Oral | 1 MG, QD | U | 0 | 1 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126186443 | 12618644 | 1 | Dementia Alzheimer's type |
| 126186443 | 12618644 | 2 | Product used for unknown indication |
| 126186443 | 12618644 | 3 | Product used for unknown indication |
| 126186443 | 12618644 | 4 | Product used for unknown indication |
| 126186443 | 12618644 | 5 | Product used for unknown indication |
| 126186443 | 12618644 | 6 | Product used for unknown indication |
| 126186443 | 12618644 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126186443 | 12618644 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126186443 | 12618644 | Choking | |
| 126186443 | 12618644 | Crying | |
| 126186443 | 12618644 | Drug ineffective | |
| 126186443 | 12618644 | Insomnia | |
| 126186443 | 12618644 | Loss of consciousness | |
| 126186443 | 12618644 | Lung disorder | |
| 126186443 | 12618644 | Nasopharyngitis | |
| 126186443 | 12618644 | Salivary hypersecretion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |